Research programme: CAR-T cell therapies - Sensei Biotherapeutics
Alternative Names: ASPH-specific CAR-T cell therapies - Sensei Biotherapeutics; ASPH-targeted CAR-T cells - Sensei Biotherapeutics; CAR-T Cell Therapies - Sensei BiotherapeuticsLatest Information Update: 28 Apr 2023
At a glance
- Originator Sensei Biotherapeutics
- Class CAR-T cell therapies; Gene therapies; Immunotherapies
- Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer